Clinical trial
A Phase 1/2 Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma
NCT01677858 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1/2 Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma
- Lead sponsor
- Amgen
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- July 4, 2012
- Completion date
- October 31, 2018
- Enrollment
- 116 (actual)
- Sites
- 35
Conditions
As the registry lists them; a condition with its own page is linked.